Pharmafile Logo

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program

June 18, 2024 |  

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life sciences companies and accelerating patient access to optimal care.

David Miller at ITN studio talking of real world evidence, HEOR, and market access

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the participation of its CEO David W. Miller in an ITN Business program on advancing healthcare. The program highlights the company’s Flexible Integrated Team (FIT) engagement model and provides insights into how such innovative approaches and advanced technology are boosting efficiencies and accelerating patient access to optimal care.

David W. Miller’s interview by leading broadcaster Alice Beer will be showcased in Advancing Healthcare, set to premiere on 12 and 13 June 2024 at the NHS ConfedExpo in Manchester, UK. This insightful program delves into the future of healthcare through the lens of innovation, preventative thinking, data-driven health solutions, and collaborative efforts. Other leading industry figures featured include NHS Confederation CEO Matthew Taylor, NHS Supply Chain CEO Andrew New, and, in an extended edition from July, Susan Rienow, President of the Association of the British Pharmaceutical Industry (ABPI). The program, which features key industry and news-style reports along with sponsored editorial profiles, will showcase Genesis Research Group’s innovative approach to agile, tech-enabled research partnerships and both its stakeholder insight platform, RPR, and its AI-powered evidence synthesis services.

David W. Miller, Chief Executive Officer of Genesis Research Group, said: “We are excited to have been invited to represent the essential work of research organizations, and to show how Genesis Research Group continues to innovate differently through our agile FIT engagement model and tech-enabled solutions. The program is an excellent platform on which to highlight our commitment to integrating innovation, stakeholder insights, and scientifically rigorous expertise to better inform decision-making and improve patient outcomes.”

You can watch the program on Genesis Research Group’s website at: www.genesisrg.com/ITN

This content was provided by Genesis Research Group

Company Details

 Latest Content from  Genesis Research Group 

Genesis Research Group survey discovers how payers are responding to Maximum Fair Prices (MFPs) under the Inflation Reduction Act

To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement platform and vetted stakeholder network to...

Genesis Research Group ISPOR Europe presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ features in scientific publication

We are pleased to share that The Evidence Base have carried out a 'deep dive' into a Genesis Research Group presentation on economic modeling in healthcare and harnessing stakeholder insights...

Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online

Genesis Research Group's poster 'Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey' was recently named as...

Innovating Differently: A Conversation with David W. Miller, CEO of Genesis Research Group

A recent interview with Dr. David W. Miller, Chairman and CEO of Genesis Research Group, about his vision for the business, the changing face of research, and their unique value proposition...

Genesis Research Group unveils enhanced US market access data analytics

Genesis Research Group (“Genesis”), a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the expansion of its real-world data analytics capabilities...

Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers

Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program

Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June’s launch of ITN Business’ “Advancing Healthcare” program for its ‘innovate differently’ approach to supporting life...

Alice Beer of ITN Business recently interviewed David W. Miller, CEO of Genesis Research Group, on ‘Advancing Healthcare’

ITN Business invited Genesis Research Group to contribute to a news style programme 'Advancing Healthcare' featuring key opinion leaders in the healthcare sector. Our CEO David W. Miller was one...

How does Genesis Research Group ‘Innovate differently’?

New Genesis Research Group CEO David W. Miller explains what we mean when we say we help our life science clients to 'Innovate differently' and transform the way they engage...

Envision Analogue – An Introduction

Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive...